by Lisa Willemse | Sep 6, 2012
It seems to me that the number of media stories on stem cell clinical trials (not just preclinical work) is on the increase. Take, for example, news last month of a new clinical trial to test cord blood stem cells as a treatment for autism. This particular...
by Michelle Ly | Jul 31, 2012
Chances are you know someone with autism spectrum disorder, or have, at the very least, been exposed to it in the media. Films like I am Sam, Rain Main, What’s Eating Gilbert Grape and well-publicized stories such as that of Hollywood starlet Jenny McCarthy and her...
by Lisa Willemse | Jun 29, 2012
With contributions from Michael Rudnicki. If you’re following recent announcements in the field, then you may know about the study published this week in Diabetes that details the use of human embryonic stem cells (hESCs) to reverse diabetes type 1 in a mouse...
by Angela C. H. McDonald | Jun 7, 2012
Late in May, the Brampton Fire Department (just outside of Toronto) held a “boot drive” to raise money for Muscular Dystrophy. My boyfriend who happens to be a firefighter tells me that boot drives are fairly common among Canadian fire departments. In fact, they are...
by Paul Krzyzanowski | May 22, 2012
Many readers may already have heard of Health Canada’s approval of Osiris’ Prochymal, a mesenchymal stem cell treatment for severe cases of pediatric Graft versus Host Disease (GvHD), with plenty of coverage circulating around the web. GvHD is a disease where...
by Lisa Willemse | Feb 1, 2012
Some updates and news items of note: Call for boycott of subscriber-based journals gains momentum The ongoing friction between proponents of open access and the academic publishers has jumped into the spotlight once again with calls from a number of academics, most...
Comments